Standout Papers

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic ste... 2022 2026 2023 2024144
  1. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial (2022)
    Naim Alkhouri, Robert Herring et al. Journal of Hepatology

Immediate Impact

57 standout
Sub-graph 1 of 20

Citing Papers

The role of the immune system in osteoarthritis: mechanisms, challenges and future directions
2025 Standout
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
1 intermediate paper

Works of Ryan S. Huss being referenced

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
2022 Standout
Synovial tissue–infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation
2010

Author Peers

Author Last Decade Papers Cites
Ryan S. Huss 334 148 147 14 479
Xiaomin Pan 264 105 93 16 562
K. Masuda 233 136 107 14 546
K. Lucas 285 251 76 12 459
H Wobser 333 117 164 22 534
S. Lombardini 355 203 113 11 527
Stephen A. Hoang 210 62 104 16 550
De Kai QIU 365 55 209 13 536
S W French 249 74 115 16 478
A Beilfuss 319 90 103 11 482
L. Mezzabotta 361 141 190 23 517

All Works

Loading papers...

Rankless by CCL
2026